Figure 6
From: Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles
(a) In vitro STAT3 gene silencing. (b) Percentage of B16 cells viability was analyzed in comparison with the untreated control using MTT assay. Each value represented mean ± standard derivation (n = 3), **P < 0.01.
